Rationale and Design for a Phase II Study Evaluating the Effect of the Cardiac Myosin Activator, CK-1827452, on Cardiac Function, Hemodynamics, and Myocardial Oxygen Consumption in Patients with Heart Failure
Publication
, Conference
Parker, JD; Michaels, AD; Kass, DA; Wolff, AA; Felker, GM; Malik, FI
Published in: Journal of Cardiac Failure
August 2008
Duke Scholars
Published In
Journal of Cardiac Failure
DOI
ISSN
1071-9164
Publication Date
August 2008
Volume
14
Issue
6
Start / End Page
S79 / S79
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1110 Nursing
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Parker, J. D., Michaels, A. D., Kass, D. A., Wolff, A. A., Felker, G. M., & Malik, F. I. (2008). Rationale and Design for a Phase II Study Evaluating the Effect of the Cardiac Myosin Activator, CK-1827452, on Cardiac Function, Hemodynamics, and Myocardial Oxygen Consumption in Patients with Heart Failure. In Journal of Cardiac Failure (Vol. 14, pp. S79–S79). Elsevier BV. https://doi.org/10.1016/j.cardfail.2008.06.438
Parker, J. D., A. D. Michaels, D. A. Kass, A. A. Wolff, G. M. Felker, and F. I. Malik. “Rationale and Design for a Phase II Study Evaluating the Effect of the Cardiac Myosin Activator, CK-1827452, on Cardiac Function, Hemodynamics, and Myocardial Oxygen Consumption in Patients with Heart Failure.” In Journal of Cardiac Failure, 14:S79–S79. Elsevier BV, 2008. https://doi.org/10.1016/j.cardfail.2008.06.438.
Parker JD, Michaels AD, Kass DA, Wolff AA, Felker GM, Malik FI. Rationale and Design for a Phase II Study Evaluating the Effect of the Cardiac Myosin Activator, CK-1827452, on Cardiac Function, Hemodynamics, and Myocardial Oxygen Consumption in Patients with Heart Failure. In: Journal of Cardiac Failure. Elsevier BV; 2008. p. S79–S79.
Parker, J. D., et al. “Rationale and Design for a Phase II Study Evaluating the Effect of the Cardiac Myosin Activator, CK-1827452, on Cardiac Function, Hemodynamics, and Myocardial Oxygen Consumption in Patients with Heart Failure.” Journal of Cardiac Failure, vol. 14, no. 6, Elsevier BV, 2008, pp. S79–S79. Crossref, doi:10.1016/j.cardfail.2008.06.438.
Parker JD, Michaels AD, Kass DA, Wolff AA, Felker GM, Malik FI. Rationale and Design for a Phase II Study Evaluating the Effect of the Cardiac Myosin Activator, CK-1827452, on Cardiac Function, Hemodynamics, and Myocardial Oxygen Consumption in Patients with Heart Failure. Journal of Cardiac Failure. Elsevier BV; 2008. p. S79–S79.
Published In
Journal of Cardiac Failure
DOI
ISSN
1071-9164
Publication Date
August 2008
Volume
14
Issue
6
Start / End Page
S79 / S79
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1110 Nursing
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology